Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Schizophrenia
100%
Circuit Level
100%
Druggability
100%
Hippocampal Hyperactivity
100%
Aberrant Salience
100%
Hippocampus
75%
Ventral Striatum
50%
Ventral Tegmental Area
50%
Drug Discovery
25%
Imaging Studies
25%
Dopamine
25%
Early Intervention
25%
Levetiracetam
25%
Disease Development
25%
Striatum
25%
Rodents
25%
Medial Prefrontal Cortex (mPFC)
25%
Anterior Cingulate Cortex
25%
Psychotic Symptoms
25%
Endophenotype
25%
Amygdala
25%
Hyperactivity
25%
Ventral Pallidum
25%
Ventral Bed nucleus of the Stria Terminalis (vBNST)
25%
Dopamine Release
25%
Neural Processing
25%
Antipsychotic Activity
25%
Therapeutic Implications
25%
Lateral Septum
25%
Acetylcysteine
25%
Metabotropic Glutamate Receptor 2 (mGluR2)
25%
Mesolimbic
25%
Glutamatergic Activity
25%
Neuroscientific Methods
25%
Modern Neuroscience
25%
Medial Septum
25%
Dopaminergic Signaling
25%
Transition to Psychosis
25%
Associative Striatum
25%
Nucleus Reuniens
25%
Brain-wide
25%
Causal Relationship
25%
Key Relay
25%
Neuroscience
Hyperactivity
100%
Schizophrenia
100%
Hippocampus
75%
Dopaminergic
50%
Striatum
50%
Ventral Tegmental Area
50%
Prefrontal Cortex
25%
Neuroscience
25%
Dopamine
25%
Ventral Striatum
25%
Amygdala
25%
Acetylcysteine
25%
Levetiracetam
25%
Cingulate Cortex
25%
Nucleus Reuniens
25%
Ventral Pallidum
25%
Stria Terminalis
25%
Dopamine Release
25%
Medial Septum
25%
Endophenotype
25%
Antipsychotic
25%
Nucleus
25%
Psychosis
25%